Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 9/20 | 0.48 |
| ▸ | ADH1B | P00325 | 1/20 | 0.48 |
| ▸ | ADH1C | P00326 | 1/20 | 0.48 |
| ▸ | ADH1A | P07327 | 1/20 | 0.48 |
| ▸ | ADH4 | P08319 | 1/20 | 0.48 |
| ▸ | ADH7 | P40394 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CASP2 | P42575 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4621467 | 1.00 | EPHX1 (0.48) | EPHX1ADH1BADH1CADH1AADH4 | |
| SCHEMBL58362 | 1.00 | — | — | |
| SCHEMBL149027 | 1.00 | EPHX1 (0.48) | EPHX1ADH1BADH1CADH1AADH4 | |
| SCHEMBL11109100 | 1.00 | EPHX1 (0.48) | EPHX1ADH1BADH1CADH1AADH4 | |
| SCHEMBL10873634 | 1.00 | EPHX1 (0.48) | EPHX1ADH1BADH1CADH1AADH4 | |
| SCHEMBL76962 | 1.00 | EPHX1 (0.48) | EPHX1ADH1BADH1CADH1AADH4 | |
| SCHEMBL148471 | 1.00 | EPHX1 (0.48) | EPHX1ADH1BADH1CADH1AADH4 | |
| SCHEMBL10874788 | 1.00 | EPHX1 (0.48) | EPHX1ADH1BADH1CADH1AADH4 | |
| SCHEMBL9661841 | 1.00 | EPHX1 (0.48) | EPHX1ADH1BADH1CADH1AADH4 | |
| SCHEMBL305122 | 1.00 | EPHX1 (0.48) | EPHX1ADH1BADH1CADH1AADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 685 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1790639-B1 | SPIROCYCLIC COMPOUNDS AND THEIR USE AS CXCR4-ANTAGONISTS | ONO PHARMACEUTICAL CO (JP) | 2014-03-26 | — | — | EP | claimed |
| US-8344142-B2 | perylenetetracarboxylic diimide core having side chains (groups or mesogens) attached to the core; to provide charge-transport materials having various volatilities, solubilities, crystallinity, and charge transport ability; organic light emitting diode; photovoltaic cells, light-emitting diodes | GEORGIA TECH RESEARCH CORPORATION (US) | 2013-01-01 | — | — | US | claimed |
| US-8039625-B2 | Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-10-18 | — | — | US | claimed |
| US-7951816-B2 | Compound containing basic group and use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2011-05-31 | — | — | US | claimed |
| US-20090044863-A1 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | NATIONAL SCIENCE FOUNDATION | 2009-02-19 | — | — | US | claimed |
| US-20080223444-A1 | Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | GEORGIA TECH RESEARCH CORPORATION | 2008-09-18 | — | — | US | claimed |
| US-7163933-B2 | Treating agent for Paget's disease of bone | TEIJIN LIMITED (JP) | 2007-01-16 | — | — | US | claimed |
| WO-2006093965-A2 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2006-09-08 | — | — | WO | claimed |
| WO-2005124453-A2 | PERYLENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2005-12-29 | — | — | WO | claimed |
| US-20030191094-A1 | Treating agent for Paget's disease of bone | TEIJIN LIMITED | 2003-10-09 | — | — | US | claimed |
| EP-1342796-A2 | Compound for the treatment of paget's disease of bone | TEIJIN LIMITED (JP) | 2003-09-10 | — | — | EP | claimed |
| EP-1189891-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION Bioscience AG (DE) | 2002-03-27 | — | — | EP | claimed |
| US-6362342-B1 | BIOSYNTHESIS; DRUG LIBRARIES | LION BIOSCIENCE AG (DE) | 2002-03-26 | — | — | US | claimed |
| WO-2001000594-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2001-01-04 | — | — | WO | claimed |
| EP-0527049-B1 | Quinophthalone compound | MITSUI CHEMICALS INC (JP) | 1998-12-23 | — | — | EP | claimed |
| EP-0457195-B1 | Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-04-15 | — | — | EP | claimed |
| US-5656604-A | HYPOTENSIVE AGENT; ENDOTHELIN ANTAGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-12 | — | — | US | claimed |
| US-5430022-A | Endothelin antagonists; hypotensive agents; treatment for angina pectoris, brain disorders, asthma, renal failure | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-04 | — | — | US | claimed |
| US-5284828-A | Hypotensive agents | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 1994-02-08 | — | — | US | claimed |
| EP-0457195-A2 | Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-11-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080223444-A1 | Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | SLC43A1, SLC3A2, SLC16A3 | EPHX1 2731/4885ADH1B 1391/4885ADH1C 2690/4885 |
| US-20090044863-A1 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | SLC18A3, CORO1C, SLC18A1 | EPHX1 3018/4885ADH1B 1551/4885ADH1C 3577/4885 |
| US-20030191094-A1 | Treating agent for Paget's disease of bone | SOST, COLGALT1, VDR | EPHX1 1305/4885ADH1B 1628/4885ADH1C 4575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.